breast cancer drug

Arvinas and Pfizer announce initial Phase 1b Data from the TACTIVE-U sub-study of Vepdegestrant in combination with Abemaciclib at 2024 San Antonio Breast Cancer Symposium

Read more

AstraZeneca’s breast cancer drug combination fails in late-stage trial

Read more

Alkem launches breast cancer treatment drug palbociclib (Palbo) in India

Read more

Dr Reddy’s launches in-house palbociclib to widen access to breast cancer drug

Read more

Eli Lilly introduces Ramiven (abemaciclib) in India

Read more

Zydus Cadila receives tentative USFDA approval for palbociclib capsules

Read more